deltatrials
Active Not Recruiting NA INTERVENTIONAL 1-arm NCT02156739

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Radiologic Detection and Characterization of Benign and Malignant Liver Lesions in Contrast-Enhanced MRI

Sponsor: M.D. Anderson Cancer Center

Conditions Hepatocellular Carcinoma Liver and Intrahepatic Bile Duct Disorder Metastatic Malignant Neoplasm in the Liver Primary Malignant Liver Neoplasm
Interventions Contrast-enhanced Magnetic Resonance Imaging Gadobutrol Gadoxetate Disodium
Updated 19 times since 2017 Last updated: Dec 18, 2025 Started: Oct 13, 2014 Primary completion: Jun 1, 2026 Completion: Jun 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hepatocellular Carcinoma and Liver and Intrahepatic Bile Duct Disorder and is currently ongoing. M.D. Anderson Cancer Center leads this study, which shows 19 recorded versions since 2014 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshot~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshot~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshot~Jun 2019 – ~Nov 2019 · 5 months · monthly snapshot~Nov 2019 – ~Jan 2020 · 2 months · monthly snapshot~Jan 2020 – ~Dec 2020 · 11 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Oct 2023 · 11 months · monthly snapshot~Oct 2023 – ~May 2024 · 7 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Jul 2025 · 5 months · monthly snapshot~Jul 2025 – ~Jan 2026 · 6 months · monthly snapshot~Jan 2026 – present · 5 months · monthly snapshot

Change History

19 versions recorded

  1. Jan 2026 — Present [monthly]

    Active Not Recruiting NA

  2. Jul 2025 — Jan 2026 [monthly]

    Active Not Recruiting NA

  3. Feb 2025 — Jul 2025 [monthly]

    Active Not Recruiting NA

  4. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting NA

  5. Aug 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

▶ Show 14 earlier versions

  1. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting NA

  2. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

  3. Oct 2023 — May 2024 [monthly]

    Active Not Recruiting NA

  4. Nov 2022 — Oct 2023 [monthly]

    Active Not Recruiting NA

  5. Sep 2022 — Nov 2022 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  6. Jan 2021 — Sep 2022 [monthly]

    Recruiting NA

  7. Dec 2020 — Jan 2021 [monthly]

    Recruiting NA

  8. Jan 2020 — Dec 2020 [monthly]

    Recruiting NA

  9. Nov 2019 — Jan 2020 [monthly]

    Recruiting NA

  10. Jun 2019 — Nov 2019 [monthly]

    Recruiting NA

  11. Jun 2018 — Jun 2019 [monthly]

    Recruiting NA

  12. Sep 2017 — Jun 2018 [monthly]

    Recruiting NA

  13. Feb 2017 — Sep 2017 [monthly]

    Recruiting NA

  14. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations